📰 Earl Strum News
Earl Strum News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Earl Strum. Real-time updates on events, politics, business and more.
June 1, 2022
Use of Pfizers COVID-19 antiviral Paxlovid spiked last week, but some doctors are reconsidering the pills for lower-risk patients after a US public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time.
May 29, 2022
Pfizer's Paxlovid use spikes, doctors reconsider its value for COVID treatment
May 29, 2022
Use of Pfizer Incs COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time.
May 29, 2022
May 28 (Reuters) - Use of Pfizer Inc's (PFE.N) COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time.
May 28, 2022
By Deena Beasley (Reuters) - Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-...
May 28, 2022
By Deena Beasley (Reuters) - Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-...
May 28, 2022
(Reuters) - Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time.